Why physicians join our pulmonology community
Sermo’s pulmonology physician network provides practicing pulmonologists with a secure, peer-driven platform to discuss the latest advances in respiratory medicine, interventional pulmonology, sleep disorders, and critical care. Whether you focus on COPD, asthma, interstitial lung disease, pulmonary hypertension, or ICU care, Sermo connects you to peers facing similar challenges—from navigating evolving treatment guidelines to managing complex, high-risk patients and balancing inpatient and outpatient demands.
Connect with leading pulmonology experts
Tap into one of the largest online communities of practicing pulmonologists across pulmonary medicine, critical care, sleep medicine, interventional pulmonology, and more.
Add to real-time clinical discussions
Engage in peer-driven conversations on diagnostic dilemmas, complex respiratory cases, ventilator management, and evolving treatment protocols.
Influence long-term respiratory care
Join discussions on managing chronic conditions like COPD, asthma, and pulmonary fibrosis, coordinating multidisciplinary care and guiding patients through long-term disease management.
Keep up with emerging pulmonology insights
Discover the latest conversations and breakthroughs in biologics for asthma, antifibrotic therapies, noninvasive ventilation strategies, and emerging diagnostics—keeping you at the forefront of your field.
Make confident treatment decisions
Access peer-reviewed drug ratings to support informed treatment decisions, grounded in real-world physician experience.
Collaborate on patient care solutions
Exchange frontline experiences, clinical protocols, and care pathways with peers in a secure, physician-only community.
Earn money sharing your pulmonology expertise
Learn why surveys are worth it for pulmonologists and tackle topics such as:
- Surveys on biologics for severe asthma and COPD
- Opinion polls on noninvasive ventilation and oxygen delivery strategies
- Research studies on interstitial lung disease and pulmonary fibrosis management
Access pulmonology drug insights from peers
Get practical, peer-reviewed information on respiratory drugs and treatments:
- Detailed safety profiles of inhaled therapies, biologics, and antifibrotic agents
- Comparative efficacy assessments
- Real-world tolerability experiences
- FDA approval timelines for new respiratory drugs and practical use cases
Learn from pulmonology articles and case studies
Discover strategies and real-world advice based on insights from physicians on Sermo.
- Managing acute exacerbations of COPD
- Communicating complex diagnoses like pulmonary fibrosis
- Barriers to adherence with inhaled therapies
- Advances in asthma phenotyping and personalized treatment approaches
Hear from fellow physician peers
This platform is truly exceptional and serves as an invaluable resource for sharing pertinent topics in the field of medicine and health. It creates a dynamic space where professionals can connect, exchange ideas, and discuss the latest advancements that impact our practice.
My favorite part of Sermo is that it allows me to learn from my peers across the world – I think that my knowledge and practice benefit so much from hearing how others approach certain medical (and other related) issues! It truly broadens and deepens my skill sets, and helps to keep me open-minded as well.
Although at first I thought the most positive aspect was the paid surveys, I have realized that the platform is a great source of shared knowledge that offers the opportunity, in a relaxed manner, to connect with colleagues from multiple medical specialties.
Frequently asked questions
Sermo’s pulmonology community regularly shares updates and discussions around FDA approvals, trial outcomes, and real-world experiences with new respiratory drugs, biologics, and medical devices.
Yes. Our drug ratings feature allows pulmonologists to review and compare medications across efficacy, safety, and tolerability—based on real-world experiences.
Absolutely. Sermo members frequently share information related to clinical trial eligibility for asthma, COPD, pulmonary fibrosis, and pulmonary hypertension, as well as recruitment challenges.
Yes. Whether your focus is outpatient pulmonary medicine, sleep medicine, or ICU-based critical care, Sermo provides a space to share your expertise and learn from others.
You’ll find case studies ranging from complex diagnostic workups and imaging interpretation to ventilator strategies and management of acute respiratory failure.
Yes. Many discussions focus on coding, reimbursement for pulmonary procedures, and the business side of running a pulmonology practice.
Sermo enables real-time collaboration. Post a case anonymously and receive input within hours—helping you make confident decisions when time and clarity matter most.
Sermo is designed to complement—not replace—professional societies and formal networks. It gives physicians a place for real-time peer discussion, specialty-specific insights, and opportunities to contribute to paid research, all within a physician-only community that fits easily into day-to-day practice.
If you’d like to see how Sermo compares with other physician networks, explore how we differ from Doximity or M3 Global.
Start your pulmonology journey on Sermo
Become part of a dynamic pulmonology physician network of over 24,000 members dedicated to advancing respiratory care through peer collaboration and expert insights.
